TECHNOLOGY | GENE THERAPY,MITOCHONDRIAL TARGETING SEQUENCE (MTS),OPTOGENETICS。 |
PIPELINE | LEBER HEREDITARY OPTIC NEUROPATHY (LHON),RETINITIS PIGMENTOSA (RP),GEOGRAPHIC ATROPHY IN DRY-AMD。 |
融资轮次 | 融资日期 | 投资方 | 融资额度 |
---|---|---|---|
Series A | 2013-04 | Versant Ventures,Novartis Venture Fund,Index Ventures,Abingworth | $32M |
Series B | 2015-07 | 未披露 | $36M |